Toggle light / dark theme

Get the latest international news and world events from around the world.

Log in for authorized contributors

The tech industry is looking to replace the smartphone — and everybody is waiting to see what Apple comes up with

Today, the most common use cases are much more mundane, including smartphone-based games and apps like Pokemon Go or Apple’s Ruler app, which use the phone’s screen and camera rather than relying on glasses or another set of screens sitting on your face. The few companies who are actively producing AR glasses are mostly focused on work scenarios, like manufacturing and medicine.


Industry watchers and participants think that Apple has a good chance to validated and revolutionize augmented reality like it did with smartphones.

This Machine Could Explore Hell for NASA

With its soaring temperatures and toxic atmosphere, Venus is a punishing place. The longest amount of time a spacecraft has survived on the planet’s surface is just over 50 minutes, when the Soviet-designed Vega 2 mission landed there in 1985.

That’s why NASA dubbed the latest challenge in its Automaton Rover for Extreme Environments (AREE) project “Exploring Hell”: Could designers build a mechanically powered robot that can withstand the harsh environment and explore the unknown world?

Mike Wang — Johns Hopkins — Hallucinogens, NeuroImmunology And The Microbiome In Mental Healthcare

Hallucinogens, neuro-immunology and the microbiome — convergent approaches in mental healthcare — mike wang, johns hopkins university.


Mike Wang, is a neuro-psychiatric researcher and adjunct teaching faculty in neuroscience at the Johns Hopkins Krieger School of Arts and Sciences.

Mike is one of the youngest principal investigators at the Johns Hopkins School of Medicine and currently leads a clinical trial examining how hallucinogenic levels of over-the-counter dextromethorphan might serve as the world’s first rapid acting oral antidepressant. (Those interested in the clinical trial for dextromethorphan can.

Mike’s work has been featured in academic journals like the American Journal of Psychiatry, as well as popular outlets like Psychology Today and VICE.

Mike received his graduate training in immunology at the Johns Hopkins Bloomberg School of Public Health studying rare viral encephalitides and neuro-immune determinants of depressive disorders.

/* */